543 related articles for article (PubMed ID: 32421144)
1. Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020.
Sood N; Simon P; Ebner P; Eichner D; Reynolds J; Bendavid E; Bhattacharya J
JAMA; 2020 Jun; 323(23):2425-2427. PubMed ID: 32421144
[TBL] [Abstract][Full Text] [Related]
2. Serosurvey of SARS-CoV-2 among hospital visitors in China.
Liang W; Lin Y; Bi J; Li J; Liang Y; Wong SS; Zanin M; Yang Z; Li C; Zhong R; Jiang G; Han G; Hu D; He J; Zhong N
Cell Res; 2020 Sep; 30(9):817-818. PubMed ID: 32686766
[No Abstract] [Full Text] [Related]
3. Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil.
Amorim Filho L; Szwarcwald CL; Mateos SOG; Leon ACMP; Medronho RA; Veloso VG; Lopes JIF; Porto LCMS; Chieppe A; Werneck GL;
Rev Saude Publica; 2020; 54():69. PubMed ID: 32638883
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 seroprevalence among parturient women in Philadelphia.
Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Gerber JS; Arevalo CP; Bolton MJ; Weirick ME; Goodwin EC; Anderson EM; Greenplate AR; Kim J; Han N; Pattekar A; Dougherty J; Kuthuru O; Mathew D; Baxter AE; Vella LA; Weaver J; Verma A; Leite R; Morris JS; Rader DJ; Elovitz MA; Wherry EJ; Puopolo KM; Hensley SE
Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32727884
[TBL] [Abstract][Full Text] [Related]
6. Patterns of IgG and IgM antibody response in COVID-19 patients.
Liu X; Wang J; Xu X; Liao G; Chen Y; Hu CH
Emerg Microbes Infect; 2020 Dec; 9(1):1269-1274. PubMed ID: 32515684
[No Abstract] [Full Text] [Related]
7. Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil.
Silveira MF; Barros AJD; Horta BL; Pellanda LC; Victora GD; Dellagostin OA; Struchiner CJ; Burattini MN; Valim ARM; Berlezi EM; Mesa JM; Ikeda MLR; Mesenburg MA; Mantesso M; Dall'Agnol MM; Bittencourt RA; Hartwig FP; Menezes AMB; Barros FC; Hallal PC; Victora CG
Nat Med; 2020 Aug; 26(8):1196-1199. PubMed ID: 32641783
[TBL] [Abstract][Full Text] [Related]
8. Detection of serum IgM and IgG for COVID-19 diagnosis.
Zhong L; Chuan J; Gong B; Shuai P; Zhou Y; Zhang Y; Jiang Z; Zhang D; Liu X; Ma S; Huang Y; Lin H; Wang Q; Huang L; Jiang D; Hao F; Tang J; Zheng C; Yu H; Wang Z; Jiang Q; Zeng T; Luo M; Zeng F; Zeng F; Liu J; Tian J; Xu Y; Long T; Xu K; Yang X; Liu Y; Shi Y; Jiang L; Yang Z
Sci China Life Sci; 2020 May; 63(5):777-780. PubMed ID: 32270436
[No Abstract] [Full Text] [Related]
9. Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study.
Makaronidis J; Mok J; Balogun N; Magee CG; Omar RZ; Carnemolla A; Batterham RL
PLoS Med; 2020 Oct; 17(10):e1003358. PubMed ID: 33001967
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020.
Fischer B; Knabbe C; Vollmer T
Euro Surveill; 2020 Jul; 25(28):. PubMed ID: 32700672
[TBL] [Abstract][Full Text] [Related]
11. Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection.
Lin Q; Zhu L; Ni Z; Meng H; You L
J Microbiol Immunol Infect; 2020 Oct; 53(5):821-822. PubMed ID: 32249185
[No Abstract] [Full Text] [Related]
12. Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19.
Liu T; Zeng G; Tao H; Shi Y; ; Wang T; Liu T; Guo F; Zhou F; Wang X
Int J Cancer; 2020 Dec; 147(11):3267-3269. PubMed ID: 32525566
[No Abstract] [Full Text] [Related]
13. Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area.
Moscola J; Sembajwe G; Jarrett M; Farber B; Chang T; McGinn T; Davidson KW;
JAMA; 2020 Sep; 324(9):893-895. PubMed ID: 32780804
[TBL] [Abstract][Full Text] [Related]
14. Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.
Lin D; Liu L; Zhang M; Hu Y; Yang Q; Guo J; Dai Y; Xu Y; Cai Y; Chen X; Huang K; Zhang Z
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2271-2277. PubMed ID: 32681308
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China.
Xu X; Sun J; Nie S; Li H; Kong Y; Liang M; Hou J; Huang X; Li D; Ma T; Peng J; Gao S; Shao Y; Zhu H; Lau JY; Wang G; Xie C; Jiang L; Huang A; Yang Z; Zhang K; Hou FF
Nat Med; 2020 Aug; 26(8):1193-1195. PubMed ID: 32504052
[TBL] [Abstract][Full Text] [Related]
16. Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho.
Bryan A; Pepper G; Wener MH; Fink SL; Morishima C; Chaudhary A; Jerome KR; Mathias PC; Greninger AL
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32381641
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of SARS-CoV-2-Specific Antibodies, Faroe Islands.
Petersen MS; Strøm M; Christiansen DH; Fjallsbak JP; Eliasen EH; Johansen M; Veyhe AS; Kristiansen MF; Gaini S; Møller LF; Steig B; Weihe P
Emerg Infect Dis; 2020 Nov; 26(11):2761-2763. PubMed ID: 32726200
[TBL] [Abstract][Full Text] [Related]
18. Reliability and usefulness of a rapid IgM-IgG antibody test for the diagnosis of SARS-CoV-2 infection: A preliminary report.
Spicuzza L; Montineri A; Manuele R; Crimi C; Pistorio MP; Campisi R; Vancheri C; Crimi N
J Infect; 2020 Aug; 81(2):e53-e54. PubMed ID: 32335175
[No Abstract] [Full Text] [Related]
19. SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.
den Hartog G; Schepp RM; Kuijer M; GeurtsvanKessel C; van Beek J; Rots N; Koopmans MPG; van der Klis FRM; van Binnendijk RS
J Infect Dis; 2020 Oct; 222(9):1452-1461. PubMed ID: 32766833
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study).
Mesnil M; Joubel K; Yavchitz A; Miklaszewski N; Devys JM
Anaesth Crit Care Pain Med; 2020 Oct; 39(5):595-596. PubMed ID: 32861816
[No Abstract] [Full Text] [Related]
[Next] [New Search]
